Novo Nordisk advanced coramitug into the Phase III CLEOPATTRA trial, evaluating 1,280 patients with amyloid transthyretin cardiomyopathy or ATTR-CM. This decision was informed by results from their ...
Q4 2025 Earnings Call February 19, 2026 3:00 AM ESTCompany ParticipantsJulien Hueber - CEO, Executive MD of PWR-Grid & ...
Claim $3000+ worth of the sportsbook promos this February 2026 with BetMGM, DraftKings, Caesars, bet365 and more offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results